Home

Jennifer Lynne Fox

CIK 1914879 · Chief Legal Officer · last filed 2026-09-08

Jennifer Lynne Fox is a Chief Legal Officer who has filed 18 SEC Form 4 insider transactions across 2 companies since 2022. The most recent filing shows the insider had shares withheld for taxes covering $14.2K of MYGN on Sep 8, 2026. Current disclosed insider exposure totals $2.5M across reported positions. 14 SEC filings were submitted jointly with Emergent BioSolutions Inc.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$2.47M

Companies

2

Total Filings

18

Lifetime Open-Market Net

$0

Filer Profile

Reported Address
322 NORTH 2200 WEST
SALT LAKE CITY, UT 84116
Related Filers
Emergent BioSolutions Inc. — 14 joint filings, latest 2024-07-12
MYRIAD GENETICS INC — 6 joint filings, latest 2026-09-08
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
MYGN Chief Legal Officer 305,964 $4.01 $1.23M $0 5 2026-09-08
EBS EVP, Ext Aff, GC, Corp Sec 186,382 $6.67 $1.24M $0 13 2024-07-12

Recent Filings

18 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-09-08 MYGN Tax (F) −4,398 -$14.2K EDGAR
2026-03-16 MYGN Mixed +189,881 -$27.9K EDGAR
2025-09-04 MYGN Tax (F) −4,435 -$30.2K EDGAR
2025-03-17 MYGN Grant (A) +63,145 $0 EDGAR
2024-09-04 MYGN Grant (A) +61,771 $0 EDGAR
2024-07-12 EBS Grant (A) +15,000 $0 EDGAR
2024-06-11 EBS Tax (F) −2,376 -$14.7K EDGAR
2024-03-15 EBS Grant (A) — $0 EDGAR
2024-03-04 EBS Tax (F) −4,806 -$15.6K EDGAR
2024-02-27 EBS Tax (F) −229 -$627 EDGAR
Showing 1–10 of 18
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.